Kursprognose für Cytek Biosciences Inc (CTKB)CTKBCytek Biosciences Inc

Alphio's CTKB stock price prediction model matches the current Cytek Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.59 (+0.05%). The 1-week path is $5.50 (-1.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Cytek Biosciences Inc (CTKB) is currently trading at $5.25, which is slightly below the average analyst target price of $5.56. However, the stock has a low Relative Strength Index (RSI) of 34.111, indicating it is oversold and may not be the best time to buy. The company has shown a year-to-date change of +6.71% and a one-year change of +29.95%, reflecting some positive momentum. Nevertheless, the forward P/E ratio is extremely high at 370.37, suggesting that the stock may be overvalued based on future earnings expectations. The main risk is the negative net income trend, with the latest reported net income of -12.16 million in Q2 2026, which raises concerns about profitability. Therefore, while there are some positive indicators, the high valuation and ongoing losses suggest that holding may be the prudent choice for now.

Cytek Biosciences Inc (CTKB) last closed at $5.59, gaining +2.95%. These facts feed the 1-day and 1-week CTKB price prediction above.